TY - JOUR
AU - Giaccherini, Matteo
AU - Farinella, Riccardo
AU - Gentiluomo, Manuel
AU - Mohelnikova-Duchonova, Beatrice
AU - Kauffmann, Emanuele Federico
AU - Palmeri, Matteo
AU - Uzunoglu, Faik
AU - Soucek, Pavel
AU - Petrauskas, Dalius
AU - Cavestro, Giulia Martina
AU - Zykus, Romanas
AU - Carrara, Silvia
AU - Pezzilli, Raffaele
AU - Puzzono, Marta
AU - Szentesi, Andrea
AU - Neoptolemos, John
AU - Archibugi, Livia
AU - Palmieri, Orazio
AU - Milanetto, Anna Caterina
AU - Capurso, Gabriele
AU - van Eijck, Casper H J
AU - Stocker, Hannah
AU - Lawlor, Rita T
AU - Vodicka, Pavel
AU - Lovecek, Martin
AU - Izbicki, Jakob R
AU - Perri, Francesco
AU - Kupcinskaite-Noreikiene, Rita
AU - Götz, Mara
AU - Kupcinskas, Juozas
AU - Hussein, Tamás
AU - Hegyi, Péter
AU - Busch, Olivier R
AU - Hackert, Thilo
AU - Mambrini, Andrea
AU - Brenner, Hermann
AU - Lucchesi, Maurizio
AU - Basso, Daniela
AU - Tavano, Francesca
AU - Schöttker, Ben
AU - Vanella, Giuseppe
AU - Bunduc, Stefania
AU - Petrányi, Ágota
AU - Landi, Stefano
AU - Morelli, Luca
AU - Canzian, Federico
AU - Campa, Daniele
TI - Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk.
JO - International journal of cancer
VL - 153
IS - 2
SN - 0020-7136
CY - Bognor Regis
PB - Wiley-Liss
M1 - DKFZ-2022-03199
SP - 373-379
PY - 2023
N1 - 2023 Jul 15;153(2):373-379
AB - Genes carrying high-penetrance germline mutations may also be associated with cancer susceptibility through common low-penetrance genetic variants. To increase the knowledge on genetic pancreatic ductal adenocarcinoma (PDAC) aetiology, the common genetic variability of PDAC familial genes was analysed in our study. We conducted a multiphase study analysing 7745 single nucleotide polymorphisms (SNPs) from 29 genes reported to harbour a high-penetrance PDAC-associated mutation in at least one published study. To assess the effect of the SNPs on PDAC risk, a total of 14 666 PDAC cases and 221 897 controls across five different studies were analysed. The T allele of the rs1412832 polymorphism, that is situated in the CDKN2B-AS1/ANRIL, showed a genome-wide significant association with increased risk of developing PDAC (OR = 1.11, 95
KW - association study (Other)
KW - genetic susceptibility (Other)
KW - pancreatic ductal adenocarcinoma (Other)
KW - single nucleotide polymorphisms (Other)
LB - PUB:(DE-HGF)16
C6 - pmid:36451333
DO - DOI:10.1002/ijc.34383
UR - https://inrepo02.dkfz.de/record/186478
ER -